Boston Scientific Corp Stock Investor Sentiment

BSX Stock  USD 100.80  1.54  1.50%   
Slightly above 68% of Boston Scientific's investor base is looking to short. The analysis of overall sentiment of trading Boston Scientific Corp stock suggests that many investors are alarmed at this time. Boston Scientific's investing sentiment can be driven by a variety of factors including economic data, Boston Scientific's earnings reports, geopolitical events, and overall market trends.

Comfort Level 32

 Alarmed

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Boston Scientific's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Boston Scientific Corp.
74.0%
18.0%
5.0%

Boston Historical Sentiment

Although Boston Scientific's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Boston, such as negative comments on social media and news outlets, may cause fear in the market and push Boston Scientific's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Boston.
  

Boston Scientific Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Boston Scientific can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
61.6%
65.0%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Boston Scientific Corp Historical Investor Sentiment

Investor biases related to Boston Scientific's public news can be used to forecast risks associated with an investment in Boston. The trend in average sentiment can be used to explain how an investor holding Boston can time the market purely based on public headlines and social activities around Boston Scientific Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Boston Scientific's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Boston Scientific and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Boston Scientific news discussions. The higher the estimate score, the more favorable the investor's outlook on Boston Scientific.

Boston Scientific Maximum Pain Price Across June 20th 2025 Option Contracts

Boston Scientific's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Boston Scientific close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Boston Scientific's options.
Calls PricePuts Price
over three weeks ago at finance.yahoo.com         
Boston Scientific Corporation Among Stocks to Invest In from Israel Englanders Portfolio
Yahoo News
over three weeks ago at finance.yahoo.com         
Disposition of 18334 shares by Michael Mahoney of Boston Scientific subject to Rule 16b-3
Yahoo News
over three weeks ago at zacks.com         
XRAY Q4 Earnings Revenues Miss Estimates, Gross Margin Down
zacks News
over three weeks ago at insidermonkey.com         
Boston Scientific Corporation Among Stocks to Invest In from Israel Englanders Portfolio
insidermonkey News
over three weeks ago at gurufocus.com         
Boston Scientific Announces Successful Pricing and Complet
Gurufocus Stories at Macroaxis
over three weeks ago at prnewswire.com         
Boston Scientific announces completion of 1.5 billion offering of senior notes
prnewswire News
over three weeks ago at gurufocus.com         
Boston Scientific announces completion of 1.5 billion offering
Gurufocus Stories at Macroaxis
over three weeks ago at nbcnews.com         
Texas probes medical schools use of bodies without consent following investigation
news
over three weeks ago at finance.yahoo.com         
Boston Scientific announces completion of 1.5 billion offering of senior notes
Yahoo News
over three weeks ago at aol.com         
Texas probes medical schools use of bodies without consent following NBC News investigation
news
over three weeks ago at gurufocus.com         
Disposition of 340 shares by Joseph Fitzgerald of Boston Scientific subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Boston Scientific Corp Completes 1.5 Billion Senior Notes
Gurufocus Stories at Macroaxis
over three weeks ago at benzinga.com         
Disposition of 2688 shares by Jeffrey Mirviss of Boston Scientific at 104.0 subject to Rule 16b-3
benzinga news
over three weeks ago at benzinga.com         
1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
benzinga news
over three weeks ago at finance.yahoo.com         
TISSIUM Strengthens Executive Leadership Team with Key Appointments
Yahoo News
Far too much social signal, news, headlines, and media speculation about Boston Scientific that are available to investors today. That information is available publicly through Boston media outlets and privately through word of mouth or via Boston internal channels. However, regardless of the origin, that massive amount of Boston data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Boston Scientific news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Boston Scientific relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Boston Scientific's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Boston Scientific alpha.

Boston Scientific Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.151234567892025FebMar 05101520
JavaScript chart by amCharts 3.21.15Boston Scientific Corp Boston Scientific Corp Dividend Benchmark Dow Jones Industrial
       Timeline  
1
Acquisition by Joseph Fitzgerald of 60 shares of Boston Scientific subject to Rule 16b-3
02/14/2025
2
Is Boston Scientific Using Too Much Debt
03/05/2025
3
PAHC vs. BSX Which Stock Should Value Investors Buy Now
03/14/2025
4
Signaturefd LLC Buys 1,368 Shares of Boston Scientific Co.
03/18/2025
5
TNDM Stock Gains on the Commercial Launch of Control-IQ Technology
03/19/2025
6
Pulsed Field Ablation Market to Hit USD 2,127.9 Million by 2032, Exhibiting a 38.90 percent CAGR SNS Insider
03/20/2025
7
Disposition of 4826 shares by Vance Brown of Boston Scientific at 100.85 subject to Rule 16b-3
03/21/2025
8
NeuroNOS Secures 2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
03/24/2025
9
How to design medtech clinical trials that deliver
03/25/2025

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.